| DNA replication |
2.34 |
0.00e+0 |
34/36 (94.44%) |
PCNA;MCM5;SSBP1;...
|
| Ribosome |
2.21 |
0.00e+0 |
113/158 (71.52%) |
MRPL20;RPS4Y1;MRPS16;...
|
| Mismatch repair |
1.99 |
0.00e+0 |
22/23 (95.65%) |
PCNA;SSBP1;POLD2;...
|
| RNA transport |
1.97 |
4.09e-3 |
128/186 (68.82%) |
EIF2S3;NUP155;CLNS1A;...
|
| Cholesterol metabolism |
1.95 |
3.27e-3 |
44/50 (88%) |
CD36;LPL;PLTP;...
|
| One carbon pool by folate |
1.93 |
2.72e-3 |
15/20 (75%) |
AMT;MTR;TYMS;...
|
| Ribosome biogenesis in eukaryotes |
1.93 |
2.33e-3 |
52/108 (48.15%) |
NHP2;RRP7A;POP4;...
|
| Fructose and mannose metabolism |
1.89 |
4.09e-3 |
30/33 (90.91%) |
SORD;GMDS;MPI;...
|
| Nucleotide excision repair |
1.80 |
9.08e-3 |
40/47 (85.11%) |
PCNA;POLD2;CCNH;...
|
| Galactose metabolism |
1.80 |
9.80e-3 |
26/31 (83.87%) |
GALE;PFKM;B4GALT1;...
|
| Cell cycle |
1.79 |
9.66e-3 |
110/124 (88.71%) |
CHEK2;PCNA;TFDP2;...
|
| Aminoacyl-tRNA biosynthesis |
1.79 |
8.85e-3 |
15/66 (22.73%) |
CARS2;LARS2;QRSL1;...
|
| Proteasome |
1.78 |
8.17e-3 |
44/46 (95.65%) |
PSMA7;POMP;PSMB4;...
|
| Spliceosome |
1.77 |
8.75e-3 |
101/150 (67.33%) |
HSPA8;LSM5;TCERG1;...
|
| PPAR signaling pathway |
1.73 |
1.53e-2 |
66/74 (89.19%) |
CD36;LPL;PLTP;...
|
| Arginine and proline metabolism |
1.70 |
2.71e-2 |
39/50 (78%) |
AOC1;CKM;ODC1;...
|
| RNA degradation |
1.65 |
3.60e-2 |
53/79 (67.09%) |
ENO3;LSM5;MTREX;...
|
| Folate biosynthesis |
1.61 |
4.77e-2 |
23/26 (88.46%) |
GCH1;QDPR;CBR1;...
|
| Epithelial cell signaling in Helicobacter pylori infect... |
-1.68 |
4.39e-2 |
62/70 (88.57%) |
PTPN11;ADAM17;HBEGF;...
|
| Mitophagy |
-1.70 |
4.07e-2 |
56/68 (82.35%) |
TBK1;OPTN;ATG5;...
|
| Adherens junction |
-1.70 |
4.28e-2 |
63/71 (88.73%) |
ACP1;SSX2IP;PTPN1;...
|
| Lysosome |
-1.71 |
4.34e-2 |
115/128 (89.84%) |
ATP6V0A4;GGA2;CLN3;...
|
| Axon guidance |
-1.74 |
3.07e-2 |
151/182 (82.97%) |
PLXNB3;SEMA4A;SRGAP3;...
|
| Regulation of actin cytoskeleton |
-1.74 |
3.14e-2 |
185/218 (84.86%) |
FGF5;APC;MAP2K2;...
|
| Rheumatoid arthritis |
-1.76 |
2.77e-2 |
78/93 (83.87%) |
ITGAL;ATP6V0A1;CD80;...
|
| Pancreatic cancer |
-1.76 |
3.07e-2 |
75/76 (98.68%) |
RALBP1;MAPK10;E2F3;...
|
| Melanoma |
-1.78 |
2.30e-2 |
68/72 (94.44%) |
FGF1;EGF;PDGFRA;...
|
| Synaptic vesicle cycle |
-1.79 |
2.47e-2 |
63/78 (80.77%) |
ATP6V0A1;NAPA;SLC17A6;...
|
| VEGF signaling pathway |
-1.83 |
2.11e-2 |
50/59 (84.75%) |
CDC42;PXN;PPP3CB;...
|
| mTOR signaling pathway |
-1.87 |
1.38e-2 |
114/154 (74.03%) |
RPS6KA2;CLIP1;LPIN1;...
|
| Proteoglycans in cancer |
-1.89 |
1.44e-2 |
172/205 (83.9%) |
TWIST1;PTPN11;HOXD10;...
|
| Ras signaling pathway |
-1.92 |
7.68e-3 |
201/232 (86.64%) |
EFNA3;PDGFC;PTPN11;...
|
| Collecting duct acid secretion |
-1.96 |
5.76e-3 |
22/27 (81.48%) |
ATP6V0A1;ATP6V0A4;ATP6V1F;...
|
| Renal cell carcinoma |
-1.98 |
1.15e-2 |
68/69 (98.55%) |
TGFB2;CUL2;RBX1;...
|
